Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis
Status:
Completed
Trial end date:
2015-04-15
Target enrollment:
Participant gender:
Summary
The study evaluates the efficacy and safety of fosfomycin and imipenem for the treatment of
methicillin-resistant staphyloccocus aureus infective endocarditis in comparison to
vancomycin, the standard therapy.